Literature DB >> 14990221

Adenosine deaminase 2 from chicken liver: purification, characterization, and N-terminal amino acid sequence.

Sachiko Iwaki-Egawa1, Chiaki Namiki, Yasuhiro Watanabe.   

Abstract

Adenosine deaminase (ADA) is involved in purine metabolism and plays an important role in the mechanism of the immune system. ADA activity is composed of two kinetically distinct isozymes, which are referred to as ADA1 and ADA2. ADA1 is widely distributed in many animals and well characterized. On the contrary, relatively little is known about ADA2. In this study, we first purified ADA2 to homogeneity from chicken liver. The purified enzyme had a molecular mass of approximately 110 kDa on gel filtration. Also, the enzyme was shown to be a homodimer with an estimated molecular mass of 61 kDa on SDS-PAGE. Following treatment with N-glycosidase, the molecular mass of ADA2 changed to 55 kDa. Several properties of the highly purified ADA2 were also investigated in this study. Furthermore, the N-terminal amino acid sequence of ADA2 was determined.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14990221     DOI: 10.1016/j.cbpc.2003.11.010

Source DB:  PubMed          Journal:  Comp Biochem Physiol B Biochem Mol Biol        ISSN: 1096-4959            Impact factor:   2.231


  6 in total

1.  Structural basis for the growth factor activity of human adenosine deaminase ADA2.

Authors:  Anton V Zavialov; Xiaodi Yu; Dorothe Spillmann; Grégoire Lauvau; Andrey V Zavialov
Journal:  J Biol Chem       Date:  2010-02-09       Impact factor: 5.157

2.  Human ADA2 belongs to a new family of growth factors with adenosine deaminase activity.

Authors:  Andrey V Zavialov; Ake Engström
Journal:  Biochem J       Date:  2005-10-01       Impact factor: 3.857

3.  Adenosine deaminase from camel tick Hyalomma dromedarii: purification and characterization.

Authors:  Tarek M Mohamed
Journal:  Exp Appl Acarol       Date:  2006-11-07       Impact factor: 2.132

4.  Phylogenetic analysis reveals a novel protein family closely related to adenosine deaminase.

Authors:  Stephanie A Maier; Julia R Galellis; Heather E McDermid
Journal:  J Mol Evol       Date:  2005-10-20       Impact factor: 3.973

Review 5.  Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment.

Authors:  Isabelle Meyts; Ivona Aksentijevich
Journal:  J Clin Immunol       Date:  2018-06-27       Impact factor: 8.317

6.  Case Report: Deficiency of Adenosine Deaminase 2 Presenting With Overlapping Features of Autoimmune Lymphoproliferative Syndrome and Bone Marrow Failure.

Authors:  Gianluca Dell'Orso; Alice Grossi; Federica Penco; Roberta Caorsi; Elena Palmisani; Paola Terranova; Francesca Schena; Michela Lupia; Erica Ricci; Shana Montalto; Filomena Pierri; Isabella Ceccherini; Francesca Fioredda; Carlo Dufour; Marco Gattorno; Maurizio Miano
Journal:  Front Immunol       Date:  2021-10-14       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.